Oxomemazine
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
|
3-(5,5-Dioxido-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine
|
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Legal status |
|
| Identifiers | |
| CAS Number | 3689-50-7 |
| ATC code | R06AD08 |
| PubChem | CID: 19396 |
| ChemSpider | 18281 |
| UNII | 305MB38V1C |
| KEGG | D07401 |
| ChEMBL | CHEMBL2104734 |
| Chemical data | |
| Formula | C18H22N2O2S |
| Molecular mass | 330.444 g/mol |
|
|
|
|
| |
Oxomemazine is an antihistamine and anticholinergic of the phenothiazine chemical class for the treatment of cough.[1][2]
See also[edit]
References[edit]
- ^ Pujet, J. C.; Keddad, K.; Sévenier, F.; Jolivet-Landreau, I. (2002). "Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study)". Therapie 57 (5): 457–463. PMID 12611200.
- ^ Lee, S. W.; Woo, C. W.; Kim, J. G. (1994). "Selectivity of oxomemazine for the M1 muscarinic receptors". Archives of pharmacal research 17 (6): 443–451. doi:10.1007/BF02979123. PMID 10319156.
|
|
|
| This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |

